0
0
0
Prompt Approval of Safe Generic Drugs Act
9/26/2024, 9:08 AM
Current Status of Bill HR 9616
Bill HR 9616 is currently in the status of Bill Introduced since September 17, 2024. Bill HR 9616 was introduced during Congress 118 and was introduced to the House on September 17, 2024. Bill HR 9616's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 17, 2024
Bipartisan Support of Bill HR 9616
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 9616
Primary Policy Focus
Alternate Title(s) of Bill HR 9616
To amend the Federal Food, Drug, and Cosmetic Act to provide for the prompt approval of drugs when safety information is added to labeling, and for other purposes.
To amend the Federal Food, Drug, and Cosmetic Act to provide for the prompt approval of drugs when safety information is added to labeling, and for other purposes.
Comments
Sponsors and Cosponsors of HR 9616
Latest Bills
Defending American Property Abroad Act of 2026
Bill HR 7084March 22, 2026
Veterans Accessibility Advisory Committee Act of 2025
Bill S 1383March 21, 2026
End Special Treatment for Congress at Airports Act of 2026
Bill S 4123March 21, 2026
Promoting Reduction of Emissions through Landscaping Equipment Act
Bill HR 7821March 21, 2026
AI Fraud Accountability Act
Bill HR 7786March 21, 2026
SURGE Act of 2026
Bill HR 7729March 21, 2026
Mathematical and Statistical Modeling Education Act
Bill S 1602March 21, 2026
Transportation Security Administration Pay Act of 2026
Bill S 4073March 21, 2026
Billion Dollar Boondoggle Act of 2025
Bill S 766March 21, 2026
Transportation Security Administration Pay Act of 2026
Bill S 4127March 21, 2026